Bjarke Henric Bjorn 4
4 · Inozyme Pharma, Inc. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Bjarke Henric Bjorn
See Remarks
Transactions
- Award
Stock option (right to buy)
2022-02-24+115,000→ 115,000 totalExercise: $5.78Exp: 2032-02-23→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 24, 2022. The shares underlying the option are scheduled to vest in equal monthly installments from February 24, 2022 through February 24, 2026.